<--- Back to Details
First PageDocument Content
Logrank test / Vandetanib / Proportional hazards models / Progression-free survival / Hazard ratio / Hazard / AstraZeneca / Statistics / Survival analysis / Chemistry
Logrank test
Vandetanib
Proportional hazards models
Progression-free survival
Hazard ratio
Hazard
AstraZeneca
Statistics
Survival analysis
Chemistry

Errata to the FDA Briefing Package

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 68,81 KB

Share Document on Facebook

Similar Documents

Statistical tests / Estimation theory / Statistical models / Proportional hazards models / Logrank test / Normal distribution / Risk / Expectation–maximization algorithm / Statistical hypothesis testing / Statistics / Survival analysis / Actuarial science

Chapter 9 Survival Analysis and the EM Algorithm Survival analysis had its roots in governmental and actuarial statistics, spanning centuries of use in assessing life expectencies, insurance rates, and annuities. In the

DocID: 1ayB6 - View Document

Logrank test / Kaplan–Meier estimator / Survival analysis / Statistics / Reliability engineering

Clinical Biostatistics Time to event data Martin Bland Professor of Health Statistics University of York

DocID: 16NWt - View Document

Logrank test / Kaplan–Meier estimator / Survival analysis / Statistics / Reliability engineering

Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York

DocID: 14RNw - View Document

Reliability engineering / Epidemiology / Actuarial science / Kaplan–Meier estimator / Logrank test / Censoring / Proportional hazards models / Billy Meier / Risk / Statistics / Survival analysis / Medical statistics

Biostatistics in Research Practice Time to event data Summary In this lecture we will look at data which are the time to an event, such as death or healing. The main problem with such data is that subjects are usually o

DocID: 14PQZ - View Document

Epidemiology / Hazard ratio / Relative risk / Logrank test / Proportional hazards models / End point of clinical trials / Docetaxel / Head and neck cancer / Randomized controlled trial / Statistics / Medical statistics / Survival analysis

What is...? series New title Statistics

DocID: 14uQU - View Document